Michael C. Donegan, Interim CFO/CAO/VP of Finance at TherapeuticsMD, Inc. (TXMD), sold 910 shares at $4.78 ($4K) on 2022-12-06, disclosed to the SEC on 2022-12-09.
Open-market sale of $4k TXMD by Interim CFO/CAO/VP of Finance. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| TXMD | SELL | 2021-12-02 | $16K | — | Filing → |
| TXMD | SELL | 2021-05-12 | $5K | — | Filing → |